London, 13 October 2014 – TechNavio, a global tech-focused research firm has announced the publication of its market research report on the Global Huntington’s Disease Therapeutics Market 2014-2018.
The market is expected to grow at a CAGR of 29.46 percent during the period 2013-2018.
Huntington’s disease is a progressive neurodegenerative disorder that can be inherited from one generation to another. It arises because of genetically programmed degeneration of neurons in some parts of the brain like the basal ganglia and cerebral cortex.
About the Report
The latest report by TechNavio focuses on the lack of safe, effective, disease-modifying treatments, which are huge unmet needs in regards to the treatment of Huntington’s disease.
The report also focuses first-in-class molecules, some interesting pipeline candidates that are undergoing development for the treatment of the disease. In some cases, these molecules may target the underlying mechanism of the disease, without causing any significant side effects.
“At present, there is no cure for Huntington’s disease and the treatment procedures for this are focused on relieving the symptoms associated with it. The drugs associated may also cause certain side effects based on their MOA and site of action. However, development of first-in-class molecules might relieve symptoms through different mechanisms, which is not offered by existing drugs,” says Faisal Ghaus, Vice President of TechNavio.
Key Information Covered in the Report:
Market segmentation, size and forecast through 2018
Market Growth Drivers:
- Unmet Medical Needs
- For a full detailed list, view our report.
Market Challenges:
- Poor Diagnosis Rates
- For a full detailed list, view our report.
Market Trends:
- Novel Mechanisms Targeted by Pipeline Candidates
- For a full detailed list, view our report.
Key Vendors:
- H. Lundbeck A/S
- Valeant Pharmaceuticals International Inc.
Other Prominent Vendors:
- Auspex Pharmaceuticals
- GlaxoSmithKline
- Ipsen
- Omeros
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
